What is Dianthus Therapeutics's net margin?

Dianthus Therapeutics (DNTH) reported net margin of -4,104.8% in Q3 2025.

How has Dianthus Therapeutics's net margin changed year-over-year?

Dianthus Therapeutics's net margin decreased by 228.3% year-over-year, from -1,250.3% to -4,104.8%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Dianthus Therapeutics DNTH Net margin

Net margin at other companies

Johnson & JohnsonJNJ

21.8%-2.6pp

AmgenAMGN

21%+3.6pp

Spyre Therapeutics, Inc.SYRE

-52,939.7%-61,871pp

Kymera TherapeuticsKYMR

-612%+602pp

Protagonist TherapeuticsPTGX

-154.9%-182pp

TG TherapeuticsTGTX

66%+55.8pp

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Enterprise value$3.88B+565%

P/S1,465.1×+962×

Profitability

See full

Operating margin-4,558.4%-9,354pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Calculated from Dianthus Therapeutics’s reported figures.

net income/total revenue=-4,104.8%

Based on trailing twelve months.

The official record: Dianthus Therapeutics’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's net margin?: Dianthus Therapeutics (DNTH) reported net margin of -4,104.8% in Q3 2025.
How has Dianthus Therapeutics's net margin changed year-over-year?: Dianthus Therapeutics's net margin decreased by 228.3% year-over-year, from -1,250.3% to -4,104.8%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.